Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis.

Anastasia-Stefania AlexopoulosAlice ParishMaren OlsenBryan C BatchCynthia MoylanMatthew J Crowley

Published in: BMJ open diabetes research & care (2023)

EBP prescriptions, especially pioglitazone, are low in patients with T2D and MASH, regardless of race/ethnicity. These data underscore the need for interventions to close the gap between current and evidence-based care.

Keyphrases

type diabetes
primary care
healthcare
palliative care
cardiovascular disease
electronic health record
physical activity
glycemic control
quality improvement
oxidative stress
big data
smoking cessation
pain management
affordable care act
emergency department
machine learning
skeletal muscle
drug induced